Mechanism of drug-induced phospholipidosis in macrophages
Project/Area Number |
21790051
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Physical pharmacy
|
Research Institution | Mukogawa Women's University |
Principal Investigator |
KURODA Yukihiro Mukogawa Women's University, 薬学部, 准教授 (60314225)
|
Project Period (FY) |
2009 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2009: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
|
Keywords | ホスホリピドーシス / マクロファージ / リポソーム / 塩基性薬物 / 両親媒性薬物 / カチオン性両親媒性薬 / リン脂質の取り込み / RAW264 / スカベンジャー受容体 / 酸性ベクシル / カチオン性両親媒性薬物 / 酸性ベシクル / リモートローディング / 弱塩基 |
Research Abstract |
The mechanism of drug-induced phospholipidosis is unclear. Among hypotheses proposed, two were examined in the present study: i) excessive cellular uptake of phospholipids and ii) neutralization of acidic vesicles by drug accumulation. Phospholipid content in the cells increased by treatment of phospholipidosis-inducing drugs as measured by DiI phospholipid probe. Increased cellular phospholipid accumulation did not decrease following treatment with inhibitors of taking-up pathways. Regardless of their phospholipidosis-inducing potential, drugs characterized by a high pKa value effectively accumulated in liposomes. This accumulation caused an upward shift of the interior pH of liposomes, which was independent of phospholipidosis-inducing potential of drugs.
|
Report
(3 results)
Research Products
(4 results)